Conatus Pharmaceuticals Inc. (CNAT) jumped 17.24% or 0.2 to $1.36. It is around 2.21 million shares traded, which is 182.72% compare to the average total volume 1.21 million. The market cap of CNAT is $45.10 million. The year to date change is -18.67%. The 52 week price range is from $1.08 to $6.74. Price of CNAT have changed -10.00% during last week. It have changed -47.06% over last month, -22.30% over last 3 months, -74.04% over last 6 months and -82.75% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CNAT is 2.03. It is 49.26% above current price. The 200-day Moving Averages for CNAT is 3.62. It is 166.18% above current price. The 52-week High is 6.74. It is 395.59% from the current price. The 52-week Low is 1.08. It is -20.59% from current price.
There are some statistics of CNAT. It is has market cap $45.10 million. The share outstanding is 33.17 million. The average volume is 1.21 million. The percent of top 15 Institution holding is 32.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CNAT is -66.46%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CNAT is -28.31%.